Skip to content

Printed from https://www.asktheeu.org/user/mathilde_de_jeu on January 19, 2026 07:10

AsktheEU.org

Menu Close
  • English
  • Deutsch
  • Español
  • Français
Sign in or sign up
  • How it works
  • Which EU body?
  • Make a request
  • Browse requests
  • Blog

Track this person

Follow
RSS feed

On this page

FOI requests
Annotations
Report inappropriate content

Mathilde de Jeu

Joined AsktheEU.org in 2024

Send message to Mathilde de Jeu

Sign in to change password, subscriptions and more (Mathilde de Jeu only)

This person's Freedom of Information requests (approximately 3)

Access to Documents Request Concerning GLP-1 Medications
Response by Health and Food Safety to Mathilde de Jeu on February 19, 2025.

Information not held

Dear Ms de Jeu, Thank you very much for your email and we are sorry to hear that you have not received our response to your applicant sent on 24 Janua...
Access to Documents Request Regarding GLP-1 Medications
Response by European Food Safety Authority to Mathilde de Jeu on January 06, 2025.

Information not held

[1]Efsa Logo                                                                                                                                         ...
Communication around GLP-1 medications
Response by European Medicines Agency to Mathilde de Jeu on November 27, 2024.

Information not held

Your message to [EMA request email] couldn't be delivered. info wasn't found at ema.europa.eu. ask+request-15259-73. . . Office 365 info Action Requ...

This person's annotations

None made.

Back to content
Access Info

A project by Access Info Europe, powered by Alaveteli

Cava de San Miguel 8, 4º centro. 28005 Madrid (Spain)

info@access-info.org

Office number (10-19 hrs CET):

+34 91 365 65 58

Out of hours mobile (any time):

+34 667 685 319

  • About
  • Contact
  • Privacy and cookies
  • API
  • AsktheEU Pro Terms

Homepage header photo © European Union 2014 - European Parliament CC-BY-ND

This website is powered by Alaveteli. Other original content was developed by Access Info Europe and is made public under a Creative Commons Attribution, Share Alike licence.

  • @AsktheEU